Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estimation of binding parameters by kinetic data analysis: differentiation between one and two binding sites.

M O Karlsson1, A Neil

  • 1Department of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, Uppsala University, Sweden.

European Journal of Pharmacology
|March 22, 1988
PubMed
Summary

This study introduces a novel kinetic method to differentiate binding models and estimate parameters using only kinetic data. The approach successfully distinguished two binding processes for [3H]noscapine in guinea pig brain homogenate.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Handling underlying discrete variables with bivariate mixed hidden Markov models in NONMEM.

Journal of pharmacokinetics and pharmacodynamics·2019
Same author

CORRIGENDUM: Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.

Clinical pharmacology and therapeutics·2018
Same author

Reduced and optimized trial designs for drugs described by a target mediated drug disposition model.

Journal of pharmacokinetics and pharmacodynamics·2018
Same author

Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials.

Journal of clinical pharmacology·2018
Same author

Meteorology of the Punjab for the Years 1867 and 1868.

The Indian medical gazette·2017

Area of Science:

  • Pharmacology
  • Biophysics
  • Biochemistry

Background:

  • Distinguishing between different binding models is crucial in pharmacology and biochemistry.
  • Equilibrium binding experiments may not always reveal complex binding kinetics or multiple binding sites.
  • Kinetic data analysis offers a complementary approach to understand ligand-receptor interactions.

Purpose of the Study:

  • To develop and validate a method for discriminating between binding models using solely kinetic data.
  • To estimate binding parameters independent of equilibrium measurements.
  • To investigate the binding kinetics of [3H]noscapine to guinea pig brain homogenate.

Main Methods:

  • Simultaneous fitting of association and dissociation experimental data to mono- or biphasic kinetic models.

Related Experiment Videos

  • Utilizing a non-linear maximum likelihood computer program for data analysis.
  • Statistical discrimination between competing binding models.

    • Main Results:

    • The developed kinetic method successfully discriminated between two distinct binding processes for [3H]noscapine.
    • This discrimination was achieved despite equilibrium binding experiments suggesting a single homogeneous population of binding sites.
    • Parameter estimates were obtained independently of equilibrium binding data.

    Conclusions:

    • The described kinetic approach enables the discrimination of binding models and parameter estimation without relying on equilibrium data.
    • This method is particularly valuable when multiple binding sites are suspected but selective ligands are unavailable.
    • The approach can serve as an independent validation for equilibrium binding experiments, assessing both Kd and Bmax.